Danavish Metformin+Teneligliptin 500mg/20mg Tablet ER
Marketer
Danavish Healthcare
Salt Composition
Metformin (500mg) + Teneligliptin (20mg)
Overview Danavish Metformin+Teneligliptin 500mg/20mg Tablet ER
Combiflox 500mg/20mg extended-release tablets, a dual-action medication, effectively manages elevated blood glucose in individuals with type 2 diabetes. This synergistic approach mitigates the risk of severe diabetic complications, including renal impairment and vision loss, and may also lessen the probability of cardiovascular events like stroke or myocardial infarction. Combiflox may be administered independently or in conjunction with other anti-diabetic therapies. Optimal efficacy is achieved through consistent use alongside a balanced diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and existing medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily intake at the same time maximizes therapeutic benefits; cessation should only occur under physician guidance. This treatment helps regulate blood sugar, thus preventing future complications. Adherence to your doctor's dietary and exercise regimen is crucial for successful diabetes management; lifestyle significantly impacts glycemic control. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal distress, and cephalalgia. Concurrent use with insulin or sulfonylureas may increase the risk of hypoglycemia; therefore, understanding its recognition and management is vital. This medication isn't universally suitable. Prior to commencing treatment, inform your doctor of any history of hepatic, renal, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals must seek medical counsel before initiating therapy. Potential drug interactions exist; disclose all medications to your physician to ensure safety. Alcohol should be minimized due to its potential to lower blood glucose. Your doctor will monitor renal function and blood glucose levels throughout the treatment period.
Primary Ingredients of Danavish Metformin+Teneligliptin 500mg/20mg Tablet ER
No information provided. Please provide the text you wish me to rephrase.
Uses of Danavish Metformin+Teneligliptin 500mg/20mg Tablet ER
Managing type 2 diabetes
Major Benefits of Danavish Metformin+Teneligliptin 500mg/20mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Danavish Metformin+Teneligliptin 500mg/20mg Extended-Release Tablet should be administered with a meal.
Common Side effects of Danavish Metformin+Teneligliptin 500mg/20mg Tablet ER:
- Nausea
- Vomiting
- Headache
- Hypoglycemia (low blood glucose level)
- Diarrhea
How to use Danavish Metformin+Teneligliptin 500mg/20mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Danavish Metformin+Teneligliptin 500mg/20mg Extended-Release tablets should be administered with a meal.
How Danavish Metformin+Teneligliptin 500mg/20mg Tablet ER works:
Danavish Metformin/Teneligliptin extended-release tablets (500mg/20mg) contain a dual-action formula to manage blood sugar levels.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Danavish Metformin+Teneligliptin 500mg/20mg ER tablets is hazardous.
PregnancyCONSULT YOUR DOCTOR
The extended-release Danavish Metformin/Teneligliptin 500mg/20mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Danavish Metformin/Teneligliptin 500mg/20mg tablet likely poses a safety risk during lactation. Available human data indicates potential transfer to breast milk, with consequent infant risk.
DrivingCONSULT YOUR DOCTOR
Driving ability while using Danavish Metformin+Teneligliptin 500mg/20mg Extended-Release Tablets is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Danavish Metformin+Teneligliptin 500mg/20mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. This medication is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverUNSAFE
Individuals with liver conditions should likely refrain from using Danavish Metformin+Teneligliptin 500mg/20mg Extended-Release Tablets due to potential safety concerns. Medical advice is recommended.
What if you forget to take Danavish Metformin+Teneligliptin 500mg/20mg Tablet ER :
Should you forget a dose of Danavish Metformin+Teneligliptin 500mg/20mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Danavish Metformin+Teneligliptin 500mg/20mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |


